Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Saliva-based molecular testing for SARS-CoV-2

Saliva-based molecular testing for SARS-CoV-2

US Patent 11926877 · Granted Mar 12, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Procaspase combination therapy for glioblastoma2025
Procaspase combination therapy for glioblastoma2025
Ion channel prosthetic compositions comprising lipid-coated crystals of amphoter2025
PAC-1 combination therapy2025
Substituted imidazo[5,1-d][1,2,3,5]tetrazines for the treatment of cancer2025
Substituted imidazo[5,1-d][1,2,3,5]tetrazines for the treatment of cancer2025
Fluorescent substrates for poly(ADP-ribosyl) hydrolases2025
Activators of the unfolded protein response2024
Ribocil C antibiotics effective for Gram-negative pathogens2024
Cancer therapy by degrading dual MEK signaling2024
Combination therapy for the treatment of uveal melanoma2024
Genotype-agnostic rescue of cystic fibrosis with small molecule bicarbonate chan2024